Alnylam Pharmaceuticals (ALNY) EPS (Basic) Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.79% |
| Dec 31, 2025 | 19.15% |
| Sep 30, 2025 | 23.53% |
| Jun 30, 2025 | 20.04% |
| Mar 31, 2025 | 38.72% |
| Dec 31, 2024 | 23.43% |
| Sep 30, 2024 | 14.64% |
| Jun 30, 2024 | 42.23% |
| Mar 31, 2024 | 21.37% |
| Dec 31, 2023 | 12.21% |
| Sep 30, 2023 | 19.97% |
| Jun 30, 2023 | -6.28% |
| Mar 31, 2023 | 0.14% |
| Dec 31, 2022 | -2.57% |
| Sep 30, 2022 | -19.90% |
| Jun 30, 2022 | -11.31% |
| Mar 31, 2022 | -9.86% |
| Dec 31, 2021 | -10.35% |
| Sep 30, 2021 | -7.29% |
| Jun 30, 2021 | -8.92% |
| Mar 31, 2021 | -7.16% |
| Dec 31, 2020 | -14.33% |
| Sep 30, 2020 | -19.09% |
| Jun 30, 2020 | -12.91% |
| Mar 31, 2020 | -21.18% |
| Dec 31, 2019 | -54.56% |
| Sep 30, 2019 | -27.05% |
| Jun 30, 2019 | -28.35% |
| Mar 31, 2019 | 14.10% |
| Dec 31, 2018 | -32.59% |
| Sep 30, 2018 | -38.32% |
| Jun 30, 2018 | -41.24% |
| Mar 31, 2018 | -56.54% |
| Dec 31, 2017 | -4.28% |
| Sep 30, 2017 | -28.67% |
| Jun 30, 2017 | -39.90% |
| Mar 31, 2017 | -37.97% |
| Dec 31, 2016 | -31.95% |
| Sep 30, 2016 | -31.31% |
| Jun 30, 2016 | -26.05% |
| Mar 31, 2016 | -26.07% |
| Dec 31, 2015 | -44.47% |
| Sep 30, 2015 | -31.66% |
| Jun 30, 2015 | -19.42% |
| Dec 31, 2014 | -8.39% |